AERI
Aerie Pharmaceuticals, Inc.
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
167 hedge funds and large institutions have $1.39B invested in Aerie Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
–
Holders Change %
0%
% of All Funds
3.3%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.16%
New
36
Increased
60
Reduced
47
Closed
36
Calls
$17.2M
Puts
$6.21M
Net Calls
+$11M
Net Calls Change
+$1.8M
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$27.6M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$26.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$26.6M |
| 4 |
Citigroup
New York
|
+$22.2M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$14.1M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$67.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$27.2M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$23.6M |
| 4 |
Goldman Sachs
New York
|
-$8.64M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.29M |
